Bulletin - June 4, 2008
This News Flash from NCI's Epidemiology and Genetics Research Program (EGRP) brings you news about:
- Comments on NIH'S Mandatory Public Access Policy for Publications Due By May 31
- Requests for Supplements to Existing NCI Projects for Collaborations in AIDS-Associated Malignancies Due By June 15
Comments on NIH'S Mandatory Public Access Policy for Publications Due By May 31
The National Institutes of Health (NIH) is seeking comment on its now mandatory Public Access Policy for publications resulting from NIH-funded research by May 31, 2008, and on the responses to Frequently Asked Questions about it. The Public Access Policy was first implemented in 2005 and compliance was voluntary. In January 2008, the policy was revised to require that as of April 7, all final peer-reviewed manuscripts arising from NIH funds must be submitted to PubMed Central (PMC) upon acceptance for publication. Furthermore, as of May 25, all NIH applications, proposals, and progress reports must include the PubMed Central reference number or NIH Manuscript Submission reference number when citing a paper that falls under the policy and is authored or co-authored by the investigator, or arose from the investigator's NIH award. (This policy includes applications submitted in advance for the May 25 due date.) PMC is a free digital archive of full-text, peer-reviewed journal articles that is managed by NIH's National Library of Medicine (NLM).
- The NIH will consider all comments and suggestions regarding the Public Access Policy. Among other issues, the NIH is particularly interested in information about the following: Do you have recommendations for alternative implementation approaches to those already reflected in the NIH Public Access Policy?
- In light of the change in law that makes NIH's public access policy mandatory, do you have recommendations for monitoring and ensuring compliance with the Public Access Policy?
- In addition to the information already posted at http://publicaccess.nih.gov/communications.htm, what additional information, training or communications related to the NIH Public Access Policy would be helpful to you?
Comments can be submitted through http://publicaccess.nih.gov/comments.htm
Review of Key Public Access Policy Web pages:
Requests for Supplements to Existing NCI Projects for Collaborations in AIDS-Associated Malignancies Due by June 15
On behalf of the National Cancer Institute (NCI), the Epidemiology and Genetics Research Program (EGRP) announces the opportunity to apply for supplemental funding for ongoing NCI-funded AIDS-associated malignancies research projects. These administrative supplements are intended to encourage and support new multidisciplinary scientific collaborations among NCI grantees, as well as with other members of the scientific community. The term "AIDS-associated malignancies" means both AIDS-defining malignancies and other malignancies whose incidence is increased in the setting of HIV infection. The supplements are offered as part of the initiative known as Activities to Promote Research Collaborations in AIDS-Associated Malignancies (APRC-AAM), which supports collaborative activities that bring together ideas and approaches from disparate scientific disciplines. Requests must be received by June 15, 2008.
The NCI is interested in encouraging applications in areas such as the study of the etiologic factors, cofactors, pathogenesis, and consequences of clinical outcome of cancers in the HIV positive population. Identifying specific contributions for the development and pathogenesis of these cancers with respect to an AIDS association will serve both to inform screening approaches and therapies targeted to the HIV infected population and increase understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection.
To be eligible for these supplements, the proposed collaborative activity must (1) be new and (2) remain within the overall scope of the active "parent" award. The Principal Investigator must have an active R01, R37, P01, U01, R33, R42, or R44 grant, with at least one full year remaining at the time of anticipated funding (September 1, 2008). A full description ofAPRC-AAM guidelines for applying.
Investigators who are interested in applying must contact their NCI Program Official prior to submitting a request to discuss whether the planned collaborations are responsive. The maximum total direct costs allowed for a collaborating unit within a consortia is $40,000 per year. The maximum combined consortium direct cost is $120,000 per year, regardless of the number of collaborators or collaborating units.
Note that the NIH Center for Scientific Review is NOT involved in receipt and processing of these requests. Refer to the Notice in the NIH GUIDE, NOT-CA-08-017, for information on where to send applications.
General inquiries about APRC-AAM may be directed to: Betsy Read-Connole, Ph.D., Division of Cancer Biology, National Cancer Institute; e-mail: email@example.com
Access the NIH Guide for Grants and Contracts for details: NOT-CA-08-017.